188 related articles for article (PubMed ID: 38267662)
1. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
[TBL] [Abstract][Full Text] [Related]
2.
Yang Z; Yan G; Zheng L; Gu W; Liu F; Chen W; Cui X; Wang Y; Yang Y; Chen X; Fu Y; Xu X
Oncoimmunology; 2021 Jun; 10(1):1938890. PubMed ID: 34221701
[TBL] [Abstract][Full Text] [Related]
3. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
4. LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP.
Hu L; Wang J; Wang Y; Wu L; Wu C; Mao B; Maruthi Prasad E; Wang Y; Chin YE
Cell Commun Signal; 2020 Sep; 18(1):148. PubMed ID: 32912229
[TBL] [Abstract][Full Text] [Related]
5. MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8
Tan L; Fu D; Liu F; Liu J; Zhang Y; Li X; Gao J; Tao K; Wang G; Wang L; Wang Z
Front Oncol; 2022; 12():1094612. PubMed ID: 36703779
[TBL] [Abstract][Full Text] [Related]
6. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.
Kasashima H; Yashiro M; Okuno T; Miki Y; Kitayama K; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
Digestion; 2018; 98(4):238-248. PubMed ID: 30045039
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
[TBL] [Abstract][Full Text] [Related]
8. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
9. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
Guo T; Peng S; Liu D; Li Y
Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
[TBL] [Abstract][Full Text] [Related]
11. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
12. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
13. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study.
Pan Z; Li Q; Feng Y; Gao C; Pan F
Medicine (Baltimore); 2022 Sep; 101(39):e30758. PubMed ID: 36181098
[TBL] [Abstract][Full Text] [Related]
15. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
Front Immunol; 2022; 13():944286. PubMed ID: 36591255
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8
Lin ZB; Long P; Zhao Z; Zhang YR; Chu XD; Zhao XX; Ding H; Huan SW; Pan YL; Pan JH
Int J Biol Sci; 2021; 17(7):1757-1768. PubMed ID: 33994860
[No Abstract] [Full Text] [Related]
17. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
18. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract][Full Text] [Related]
19. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
Ma P; Sun W
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
